🇺🇸 FDA
Company

LEXICON

LEXICON PHARMACEUTICALS, INC.

LXRX pharma USA

Quick answer

LEXICON is a pharma company (LXRX) headquartered in THE WOODLANDS, TX, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Placebo

Type 2 Diabetes Mellitus

Phase 3 · small_molecule · completed

2 trials project

Placebo

Type 1 Diabetes Mellitus

Phase 3 · small_molecule · completed

2 trials project

Sotagliflozin

Type 2 Diabetes Mellitus

Phase 3 · small_molecule · terminated

3 trials project

Sotagliflozin

Obstructive Cardiomyopathy, Hypertrophic

Phase 3 · small_molecule · active

1 trials project

Sotagliflozin

Type 1 Diabetes Mellitus

Phase 3 · small_molecule · completed

3 trials project

Sotagliflozin

Diabetic Nephropathies

Phase 3 · small_molecule · active

1 trials project

Sotagliflozin

Type 1 Diabetes Mellitus (T1DM)

Phase 3 · small_molecule · completed

1 trials project

Sotagliflozin

Heart Failure

Phase 3 · small_molecule · terminated

2 trials project

Sotagliflozin (SAR439954)

Type 2 Diabetes Mellitus

Phase 3 · small_molecule · completed

4 trials project

Sotagliflozin Low Dose

Type 1 Diabetes (T1D)

Phase 3 · small_molecule · active

1 trials project

Telotristat etiprate

Carcinoid Syndrome

Phase 3 · small_molecule · completed

5 trials project

250 mg LX1033 tablets

Irritable Bowel Syndrome

Phase 2 · small_molecule · completed

1 trials project

75 mg LX4211

Type 2 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

Gemcitabine

Locally Advanced Unresectable Pancreatic Adenocarcinoma

Phase 2 · small_molecule · completed

1 trials project

LX1031 High Dose

Irritable Bowel Syndrome

Phase 2 · small_molecule · completed

1 trials project

LX3305 low dose

Rheumatoid Arthritis

Phase 2 · small_molecule · completed

1 trials project

LX4211 Low Dose

Type 2 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

LX6171 High Dose

Age-Related Memory Disorders

Phase 2 · small_molecule · completed

1 trials project

LX7101 (0.125%)

Primary Open-angle Glaucoma

Phase 2 · small_molecule · completed

1 trials project

LX9211

Diabetic Peripheral Neuropathy

Phase 2 · small_molecule · completed

1 trials project

Placebo

Postherpetic Neuralgia

Phase 2 · small_molecule · completed

1 trials project

Placebo (blinded)

Diabetic Peripheral Neuropathic Pain

Phase 2 · small_molecule · completed

1 trials project

Sotagliflozin

Cardiac Failure Aggravated

Phase 2 · small_molecule · terminated

1 trials project

Sotagliflozin

Type 1 Diabetes

Phase 2 · small_molecule · active

2 trials

Drugs (1)

drug

sotagliflozin

INPEFA

Patents (8)

patent

US 12344596

Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-d

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11730723

Compounds and methods for treating viral infections

Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11666575

Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral

Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11059907

Antibodies that bind Notum Pectinacetylesterase

Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10106569

Inhibitors of sodium glucose transporter 1 for constipation

Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9862724

Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and met

Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9688710

Inhibitors of sodium glucose cotransporter 1

Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9682982

Inhibitors of adapter associated kinase 1, compositions comprising them, and met

Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)